Targeted therapy for the adjuvant treatment of stage III BRAF-mutated melanoma.

Targeted therapy for the adjuvant treatment of stage III BRAF-mutated melanoma.
Clin Adv Hematol Oncol. 2018 Jan;16(1):25-27
Authors: Long G
PMID: 29741501 [PubMed - in process]

Source: Clinical Advances in Hematology and Oncology - May 11, 2018 Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research